-
41.发明申请公开(公告)号：US20200175318A1
公开(公告)日：2020-06-04
申请号：US16787467
申请日：2020-02-11
发明人： Koji YOKOUCHI , Masanobu TAKASHIMA
摘要： A medicine inspection support device, an image processing device, an image processing method and a program are provided that appropriately recognize identification information irrespective of whether the identification information is an engraved mark or a printed character. The image processing device obtains a plurality of taken images of a second medicine with light illumination directions to the surface of the second medicine different from each other, generates a first enhanced image by performing a process of enhancing an engraved mark portion of the second medicine, generates a second enhanced image by performing a process of enhancing a printed character portion of the second medicine, and collates the image designated by the designation information designating one of the first enhanced image and the second enhanced image as an image to be used for collation with the master image to determine whether the first medicine is identical to the second medicine.
-
公开(公告)号：US10660821B2
公开(公告)日：2020-05-26
申请号：US15119604
申请日：2015-02-17
发明人： Katsuhiro Tsuno
摘要： Provided is a compact lightweight transport box in which the internal temperature distribution is minimized and accurate temperature regulation can be performed. The transport box includes an insulating container, an internal heat conducting container mounted in the insulating container, and an insulating cover body with a cover internal side heat conducting plate exposed on an inner surface facing the opening part of the internal heat conducting container, in which, with the opening part of the insulating container closed by the insulating cover body, the cover internal side heat conducting plate is near an opening end of the internal heat conducting container.
-
43.发明申请公开(公告)号：US20200151495A1
公开(公告)日：2020-05-14
申请号：US16744559
申请日：2020-01-16
发明人： Kazuchika IWAMI
摘要： A drug identification device, an image processing device, an image processing method, and a program are provided that appropriately determine whether identification information added to a drug is added by mark engraving or by character printing. The above problem is solved by an image processing device including: an obtaining unit configured to obtain a plurality of images of a drug having identification information added by mark engraving or by character printing on a surface of the drug, with emitting directions of light to the surface different from each other; an image comparing unit configured to compare the plurality of images with each other; and a determining unit configured to determine whether the identification information is added by mark engraving or by character printing, according to a comparison result by the image comparing unit.
-
公开(公告)号：US20200058392A1
公开(公告)日：2020-02-20
申请号：US16662233
申请日：2019-10-24
发明人： Kazuchika IWAMI
摘要： An object of the present invention is to provide a dispensing audit support apparatus and a dispensing audit support method with a high collation accuracy robustness. According to a dispensing audit support apparatus according to one aspect of the present invention, since a position, shape and size of a region of interest are set according to a position of a collation-target medicine in a captured image, and a position, shape and size of a master image are set according to the set region of interest, it is possible to avoid or reduce distortion of the medicine shape, blur, inclusion of an end part into the image, and the like due to the position and orientation of the collation-target medicine. Therefore, influence on collation accuracy is small, and it is possible to enhance the robustness of the collation accuracy.
-
公开(公告)号：US20190336476A1
公开(公告)日：2019-11-07
申请号：US16474374
申请日：2017-12-28
摘要： The object of the present invention is to provide a solid pharmaceutical composition in which both the pre-bitter taste and the post-bitter taste of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof are suppressed. The present invention provides a solid pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and a compound having at least one hydrocarbon group having 8 to 18 carbon atoms and a sulfo group or a salt thereof.
-
公开(公告)号：US20190194146A1
公开(公告)日：2019-06-27
申请号：US16293100
申请日：2019-03-05
发明人： Tetsuro UCHIDA , Sayuri Uehara , Takayoshi Tsuzuki , Yusuke Okubo , Yuta Kobayashi , Yu Koseki
IPC分类号： C07D241/24
CPC分类号： C07D241/24
摘要： The purpose of the present invention is to provide a method for producing 6-bromo-3-hydroxy-2-pyrazinecarboxamide in which the content ratio of impurities is reduced. This production method includes a step of obtaining 6-bromo-3-hydroxy-2-pyrazinecarboxamide crystal having diffraction angles expressed in degrees 2θ of 5.5, 20.1, 23.7, 26.7, 27.5, and 28.1° and/or diffraction angles expressed in degrees 2θ of 7.1, 21.4, 25.2, 25.7, 27.1, and 28.8° in powder X-ray diffraction.
-
公开(公告)号：US10308642B2
公开(公告)日：2019-06-04
申请号：US15765011
申请日：2016-10-05
发明人： Kazuki Shimane , Yasuhito Tanaka
IPC分类号： A61K31/4422 , A61P31/20 , C07D409/04 , C07D213/80 , A61K31/443 , A61K31/4436 , A61K31/4439 , C07D405/10 , C07D409/10
摘要： An anti-hepatitis B virus agent comprising a compound represented by general formula [1], wherein R1 represents an aryl group, which may be substituted, or the like; R2 represents an aryl group, which may be substituted, or the like; and R3 represents a hydrogen atom or the like; or a salt thereof.
-
公开(公告)号：US20240325386A1
公开(公告)日：2024-10-03
申请号：US18292972
申请日：2022-07-28
发明人： Tsutomu SAKURAI , Takahiro YAMATAKE
IPC分类号： A61K31/4965 , A61P31/14
CPC分类号： A61K31/4965 , A61P31/14
摘要： The present invention provides a therapeutic agent for novel coronavirus infection comprising 6-fluoro-3-hydroxy-2-pyrazinecarboxamide or a salt thereof as an active ingredient, which is administered to novel coronavirus infection patients testing negative for either one or both of IgG antibody against novel coronavirus and IgA antibody against novel coronavirus.
-
公开(公告)号：US20240189305A1
公开(公告)日：2024-06-13
申请号：US18554291
申请日：2022-03-30
发明人： Tsutomu SAKURAI , Takahiro YAMATAKE
IPC分类号： A61K31/4965 , A61P31/14
CPC分类号： A61K31/4965 , A61P31/14
摘要： The present invention makes it possible to treat a coronavirus infection by administering a pharmaceutical composition containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide or a salt thereof as an active ingredient to a patient infected with the coronavirus who has an aggravating risk factor and is in an early stage of the disease.
-
公开(公告)号：US20240092519A1
公开(公告)日：2024-03-21
申请号：US18470992
申请日：2023-09-20
发明人： Jun SATO
摘要： An imaging assisting apparatus includes: a first member in which a packaging bag containing a drug is placed, and has a first surface disposed on a side opposite to a surface to be imaged of the packaging bag; a second member which extends from the first member toward a side opposite to the first surface where the packaging bag is placed, and is configured to suppress incidence of environmental light on the packaging bag placed in the first member; and a third member which extends from the first member toward the side opposite to the first surface where the packaging bag is placed, and is disposed on a side opposite to the second member across the first member.
-
-
-
-
-
-
-
-
-
搜索结果
90 条记录 (耗时 0.063 秒)
